145
Participants
Start Date
December 27, 2023
Primary Completion Date
January 27, 2025
Study Completion Date
January 27, 2025
Lotilaner ophthalmic solution, 0.25%
XDEMVY (lotilaner ophthalmic solution) 0.25%, administered topically twice a day for approximately 43 days
Vehicle control
Vehicle of XDEMVY administered topically twice a day for approximately 43 days
Site, Cranberry Township
Site, Shelby
Site, Delray Beach
Site, Memphis
Site, Louisville
Site, Powell
Site, Indianapolis
Site, Edina
Site, Fargo
Site, Pittsburg
Site, Houston
Vision Institute, Colorado Springs
Site, Cave Creek
Site, Long Beach
Tarsus Pharmaceuticals, Inc.
INDUSTRY